Exhale

The official blog of the Lung Institute.

COPD vs Pulmonary Fibrosis: Here’s What You Need to Know

COPD vs. Pulmonary Fibrosis: Here's What You Need to Know

COPD or Pulmonary Fibrosis? Find out the difference here.

Chronic lung disease in any form can often be a debilitating affliction, dramatically affecting one’s quality of life, energy levels, and even appearance. Respiratory illness is a growing concern among not only Americans but the world at large. For many, Chronic Obstructive Pulmonary Disease (COPD) is often the most prevalent. However, even though pulmonary fibrosis may be less common, its effects are generally fatal. Though both diseases can be experienced simultaneously, the two illnesses are drastically different in a variety of ways.

The Lung Institute is here to inform and to empower, and with your health in mind, we’ll look at the difference between COPD and Pulmonary Fibrosis, and what you can do about it. When it comes to COPD vs Pulmonary Fibrosis, here’s what you need to know.

Obstructive vs Restrictive

COPD vs Pulmonary Fibrosis: Here's What You Need to Know

Within respiratory disease, there are two classifications: obstructive and restrictive. While obstructive respiratory disease is characterized by the difficulty of expelling oxygen, restrictive respiratory disease is defined by the struggle to fully expand the lungs.

In obstructive pulmonary disease, after the lungs are damaged or the airways become narrowed, exhaled air comes out more slowly than normal. This makes it harder to breathe, particularly after strenuous activity or exertion. As the rate of breathing is increased, there is less time to breathe out all the air before the next inhalation, creating the sensation of feeling out of breath.

While in restrictive pulmonary disease, the lungs themselves are restricted from fully expanding. Whether as a result of stiffness of the chest, weak muscles, damaged nerves or internal scarring, restriction of the lungs from expanding creates a similar sensation of breathlessness.

 COPD

COPD vs Pulmonary Fibrosis: Here's What You Need to Know

Although encompassing several obstructive lung diseases (emphysema, chronic bronchitis, and at times, asthma, bronchiectasis and cystic fibrosis) COPD is pretty common, affecting 600 million people worldwide. As an obstructive lung disease, it is characterized by poor airflow, inflammation and dilation of the airways, and is known to worsen over time. Occurring primarily as the result of direct inhalation of smoke or other harmful particulates, the obstruction to breathing stems from a concurrence of airway inflammation and emphysema.

Signs and Symptoms Include

  • Cough
  • Shortness of breath
  • Chest tightness
  • Fatigue

How You Can Treat It

  • Corticosteroids
  • Oxygen Therapy
  • Nutrition & Exercise
  • Cellular Therapy

Pulmonary Fibrosis

COPD vs Pulmonary Fibrosis: Here's What You Need to Know

Pulmonary Fibrosis (PF) literally means “scarring of the lungs” and it permanently scars the lungs of over 5 million people worldwide. It is a respiratory disease characterized by the excessive build-up of scar tissue leading to a thickening of the walls. This ultimately causes reduced oxygen supply to the blood and leads to shortness of breath. However, the key difference between the two diseases is that the cause of PF compared to COPD is often difficult to diagnose. In comparison to COPD, pulmonary fibrosis is not always connected to smoke or other inhalants, and in some cases can occur as a result of a genetic predisposition to the disease. This status of an unknown origin often leads to the diagnosis of idiopathic pulmonary fibrosis (IPF).

Signs and Symptoms Include

  • Shortness of breath
  • Chronic cough
  • Fatigue and weakness
  • Chest discomfort
  • Loss of appetite and rapid weight loss

How You Can Treat It

  • Medication that suppresses the body’s immune system (Pirfenidone, prednisone)
  • Oxygen Therapy
  • Cellular Therapy

As new discoveries are being made in the field of cellular research, this is an exciting time for the treatment of respiratory illness. As the scientific community continues to put their best minds to the task of solving the problems and complications of the human body, we will continue to bring these advancements to the public with the hope of bettering the quality of life for those who need it most.

If you’re looking to make a profound change in your life or the life of someone you love, the time is now. If you or a loved one suffers from COPD, or another lung disease, the Lung Institute may be able to help with a variety of cellular treatment options. Contact us at (800) 729-3065 to find out if you qualify for cellular therapy.

Do you have COPD or Pulmonary Fibrosis? We want to hear from you. Share your thoughts and comments on COPD vs Pulmonary Fibrosis: Here’s What You Need to Know below.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.